Results: The mean age (range) of the paediatric groups were: IBD 13.3 years (8–18), without IBD 11.9 years (8–15). Repeat assessments by the IBD group determined test-retest reliability ( n = 21). Between-group differences were tested using ANOVA and pairwise comparisons made with the IBD group. Methods: IBD-KID2 was administered to 4 participant groups in Christchurch Hospital, New Zealand: children with IBD ( n = 22), children without IBD ( n = 20), medical staff ( n = 15), and administration staff ( n = 15). Objectives: In order to examine validity and reliability, a study was carried out using IBD-KID2 in a paediatric IBD population and a number of comparator groups with established levels of IBD knowledge. IBD-KID2 is a knowledge assessment tool written for children aged 8 years and over with IBD. Assessing their knowledge is vital to identify deficits that may affect disease management. Introduction: For children with inflammatory bowel disease (IBD), acquired knowledge of their condition and treatment is integral to their adherence and self-management.
0 kommentar(er)
